Cochrane · systematic review · CD002252

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy

Abalos, E, Duley, L, Steyn, DW, et al. · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library

Pregnancy and ChildbirthAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
15
current version
GRADE rated
11
No studies
4
Included studies
NR
No studies 4 · 26.7%Ungraded 0 · 0%Very low 3 · 20%Low 3 · 20%Moderate 5 · 33.3%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Any antihypertensive drug compared to no antihypertensive drugs/placebo for mild to moderate hypertension during pregnancy (primary outcomes)

Population: women with mild to moderate hypertension during pregnancy
7 questions
OutcomeEffectEvidenceStatus / GRADE
Maternal
Any antihypertensive drug vs no antihypertensive drugs/placebo
no estimate extractedNRNo studies
Severe hypertension
Any antihypertensive drug vs no antihypertensive drugs/placebo
RR 0.49 [0.4, 0.6]20 studies · 2558 participantsModerate
Proteinuria/pre‐eclampsia
Any antihypertensive drug vs no antihypertensive drugs/placebo
RR 0.92 [0.75, 1.14]23 studies · 2851 participantsLow
Fetal/neonatal/infant
Any antihypertensive drug vs no antihypertensive drugs/placebo
no estimate extractedNRNo studies
Total reported fetal or neonatal deaths (including miscarriage)
Any antihypertensive drug vs no antihypertensive drugs/placebo
RR 0.72 [0.5, 1.04]29 studies · 3365 participantsModerate
Small‐for‐gestational age
Any antihypertensive drug vs no antihypertensive drugs/placebo
RR 0.96 [0.78, 1.18]21 studies · 2686 participantsModerate
Preterm birth (< 37 weeks)
Any antihypertensive drug vs no antihypertensive drugs/placebo
RR 0.96 [0.83, 1.12]15 studies · 2141 participantsModerate

Any antihypertensive drug compared to no antihypertensive drugs/placebo for mild to moderate hypertension during pregnancy (secondary maternal and fetal/neonatal/infant outcomes)

Population: women with mild to moderate hypertension during pregnancy
8 questions
OutcomeEffectEvidenceStatus / GRADE
Maternal
Any antihypertensive drug vs no antihypertensive drugs/placebo
no estimate extractedNRNo studies
Maternal death
Any antihypertensive drug vs no antihypertensive drugs/placebo
RR 1.11 [0.18, 7.02]5 studies · 525 participantsVery low
Severe pre‐eclampsia
Any antihypertensive drug vs no antihypertensive drugs/placebo
RR 0.56 [0.15, 2.02]3 studies · 416 participantsVery low
Eclampsia
Any antihypertensive drug vs no antihypertensive drugs/placebo
RR 0.52 [0.13, 2.06]7 studies · 713 participantsVery low
Changed/stopped drugs due to maternal side‐effects
Any antihypertensive drug vs no antihypertensive drugs/placebo
RR 1.93 [0.92, 4.06]16 studies · 1503 participantsLow
Elective delivery (induction of labour + elective caesarean section)
Any antihypertensive drug vs no antihypertensive drugs/placebo
RR 0.93 [0.84, 1.04]4 studies · 710 participantsModerate
Fetal/neonatal/infant
Any antihypertensive drug vs no antihypertensive drugs/placebo
no estimate extractedNRNo studies
Admission to neonatal or intensive care nursery
Any antihypertensive drug vs no antihypertensive drugs/placebo
RR 1.01 [0.83, 1.22]10 studies · 1570 participantsLow